Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice
Jianxiong Zeng, Xiaochun Xie, Xiaoli Feng, et al.
EBioMedicine (2021) Vol. 75, pp. 103803-103803
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein
Eduardo A. Albornoz, Alberto A. Amarilla, Naphak Modhiran, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 7, pp. 2878-2893
Open Access | Times Cited: 126
Activation of innate immune cGAS-STING pathway contributes to Alzheimer’s pathogenesis in 5×FAD mice
Xiaochun Xie, Guanqin Ma, Xiaohong Li, et al.
Nature Aging (2023) Vol. 3, Iss. 2, pp. 202-212
Open Access | Times Cited: 110
Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets
Lieselotte Vande Walle, Mohamed Lamkanfi
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 1, pp. 43-66
Closed Access | Times Cited: 102
Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications
Nicola Potere, Marco Giuseppe Del Buono, Roberto Caricchio, et al.
EBioMedicine (2022) Vol. 85, pp. 104299-104299
Open Access | Times Cited: 78
Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 78
Innate immunity, cytokine storm, and inflammatory cell death in COVID-19
Rajendra Karki, Thirumala‐Devi Kanneganti
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 72
Hyperinflammatory Response in COVID-19: A Systematic Review
Marcos Jessé Abrahão Silva, Layana Rufino Ribeiro, Maria Isabel Montoril Gouveia, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 553-553
Open Access | Times Cited: 70
Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19
Xue Li, Ziqi Zhang, Zhenling Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 49
The Potential Role of Growth Differentiation Factor 15 in COVID-19: A Corollary Subjective Effect or Not?
Ahmad O. Babalghith, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2051-2051
Open Access | Times Cited: 43
The role of cell death in SARS-CoV-2 infection
Cui Yuan, Zhenling Ma, Jiufeng Xie, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 36
NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis
Nicola Potere, Evan C. Garrad, Yogendra Kanthi, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 11, pp. 2046-2060
Open Access | Times Cited: 30
Fatal outcome of severe fever with thrombocytopenia syndrome (SFTS) and severe and critical COVID‐19 is associated with the hyperproduction of IL‐10 and IL‐6 and the low production of TGF‐β
Su Yeon Kang, Jeong Rae Yoo, Yejin Park, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 7
Open Access | Times Cited: 26
Microbial infection promotes amyloid pathology in a mouse model of Alzheimer’s disease via modulating γ-secretase
Meng Zhao, Guanqin Ma, Xiaoxu Yan, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 5, pp. 1491-1500
Closed Access | Times Cited: 8
Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19
R. K. Subbarao Malireddi, Bhesh Raj Sharma, Thirumala‐Devi Kanneganti
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 615-645
Closed Access | Times Cited: 8
NLRP3 inflammasome activation and SARS-CoV-2-mediated hyperinflammation, cytokine storm and neurological syndromes.
Debashis Dutta, Jianuo Liu, Huangui Xiong
PubMed (2022) Vol. 14, Iss. 3, pp. 138-160
Closed Access | Times Cited: 32
Pyroptosis and Its Role in SARS-CoV-2 Infection
Zsofia Bittner, Markus Schrader, Shilpa Elizabeth George, et al.
Cells (2022) Vol. 11, Iss. 10, pp. 1717-1717
Open Access | Times Cited: 31
Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: from prognostic marker to therapeutic agent
Jozefien Declercq, Elisabeth De Leeuw, Bart N. Lambrecht
Cytokine (2022) Vol. 157, pp. 155934-155934
Open Access | Times Cited: 29
Ferroptosis and pyroptosis signatures in critical COVID-19 patients
Cédric Peleman, Samya Van Coillie, Symen Ligthart, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 9, pp. 2066-2077
Open Access | Times Cited: 20
Tranilast-matrine co-amorphous system: Strong intermolecular interactions, improved solubility, and physiochemical stability
Dandan Hu, Xin Chen, Duanxiu Li, et al.
International Journal of Pharmaceutics (2023) Vol. 635, pp. 122707-122707
Closed Access | Times Cited: 18
SARS-CoV-2-Mediated Lung Edema and Replication Are Diminished by Cystic Fibrosis Transmembrane Conductance Regulator Modulators
José M. Honrubia, Francisco J. Gutierrez-Alvarez, Alejandro Sanz‐Bravo, et al.
mBio (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
SARS-CoV-2 Nsp2 Contributes to Inflammation by Activating NF-κB
Émile Lacasse, Leslie Gudimard, Isabelle Dubuc, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 334-334
Open Access | Times Cited: 15
Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology
Man Wang, Fei Yu, Wenguang Chang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Potential convergence of olfactory dysfunction in Parkinson’s disease and COVID-19: The role of neuroinflammation
Hui Li, Junliang Qian, Youcui Wang, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102288-102288
Closed Access | Times Cited: 6
Levodopa Improves Behavioral Deficits of Mice with Parkinson's Disease Symptoms via Curbing NLRP3 Inflammasome Activation and Enhancing Tyrosine Hydroxylase Levels in the Striatum and Substantia Nigra
Xi Chen, Zhao Wang, Weihua Yang, et al.
Journal of Integrative Neuroscience (2024) Vol. 23, Iss. 1, pp. 2-2
Open Access | Times Cited: 5
NLRP3 Inflammasomes: Dual Function in Infectious Diseases
Yanbo Li, Rui Qiang, Zheng-Min Cao, et al.
The Journal of Immunology (2024) Vol. 213, Iss. 4, pp. 407-417
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top